Author:
Abolhassani Hossein,Bashiri Ghazal,Montazeri Mahdi,Kouchakzadeh Hasan,Shojaosadati Seyed Abbas,Siadat Seyed Ehsan Ranaei
Reference372 articles.
1. Tu Y-F, Chien C-S, Yarmishyn AA, Lin Y-Y, Luo Y-H, Lin Y-T, Lai W-Y, Yang D-M, Chou S-J, Yang Y-P (2020) A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci 21(7):2657
2. Oroojalian F, Haghbin A, Baradaran B, Hemat N, Shahbazi M-A, Baghi HB, Mokhtarzadeh A, Hamblin MR (2020) Novel insights into the treatment of SARS-CoV-2 infection: an overview of current clinical trials. Int J Biol Macromol
3. Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MA, Urquiza J, Ramírez D, Alonso C, Campillo NE (2020) COVID-19: drug targets and potential treatments. J Med Chem
4. Pandey A, Nikam AN, Shreya AB, Mutalik SP, Gopalan D, Kulkarni S, Padya BS, Fernandes G, Mutalik S, Prassl R (2020) Potential therapeutic targets for combating SARS-CoV-2: drug repurposing, clinical trials and recent advancements. Life Sci 117883
5. Singh TU, Parida S, Lingaraju MC, Kesavan M, Kumar D, Singh RK (2020) Drug repurposing approach to fight COVID-19. Pharmacol Rep 1–30